Appointment dossier — Colon Cancer
Bring this to your appointment. It summarizes what published studies report — it is not medical advice and does not say anything works. Decisions are yours and your care team’s.
Compounds studied in Colon Cancer
- Bevacizumab — Human evidence · 0 positive / 1 negative-mixed · PMID 40434540, 37217995
“Positive” means a study reported a positive result — most are early lab/animal work that may not translate to people.
Open recruiting trials (18)
- NCT07290309 — Survivors Uniting for Remote Guided Exercise (United States)
- NCT05529615 — Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer (China)
- NCT06917963 — Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1 (Poland)
- NCT06989814 — Smart Measurement of Circulating Tumor DNA (Netherlands)
- NCT07341737 · Phase 1 / Phase 2 — SL-28 for Advanced Solid Tumours (Australia)
- NCT06710756 · Phase 1 / Phase 2 — Lead-212 PSV359 Therapy for Patients With Solid Tumors (United States)
- NCT06004245 · Phase 1 — A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors (United States)
- NCT07630961 · Phase 1 — Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors (Denmark)
- NCT07760012 — 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors (China)
- NCT05349227 — Comprehensive Outcomes for After Cancer Health (United States)
- NCT05726136 · Phase 4 — Fluid Challenge and Plasma Volume, During Surgery (Sweden)
- NCT05515354 · Phase 4 — Smoking Cessation and Menstrual Cycle Phase (Canada)
- NCT05606692 · Phase 4 — Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics) (Taiwan)
- NCT06758830 · Phase 2 / Phase 3 — Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. (Lithuania)
- NCT06634875 · Phase 2 — Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) (United States)
- NCT06341296 · Phase 2 — Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer (China)
- NCT05310643 · Phase 2 — Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC (France)
- NCT07235293 · Phase 2 — A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. (United States)
Most-relevant first: trials that name Colon Cancer, then broader trials you may still qualify for. 1205 recruiting trials name this cancer on ClinicalTrials.gov. Eligibility is decided by each trial's team — bring these NCT numbers to your appointment.
Financial help to look into
- PAN Foundation — Copay assistance funds by diagnosis (funds open and close as money allows). https://www.panfoundation.org/
- HealthWell Foundation — Copay and premium assistance funds by disease. https://www.healthwellfoundation.org/
- CancerCare — financial assistance — Limited grants plus free financial counseling. https://www.cancercare.org/financial
- Family Reach — Help with everyday living costs (rent, transport, food) during treatment. https://familyreach.org/
- NeedyMeds — Searchable directory of drug patient-assistance and discount programs. https://www.needymeds.org/
For each medicine above, search manufacturer and nonprofit programs at medicineassistancetool.org.
Questions to ask your oncologist
- I've read that Bevacizumab has been studied in people for Colon Cancer — what's the evidence, and is it an option or available in a trial for me?
- Of the open trials I found (for example NCT07290309), am I eligible for any — here or at a larger cancer center?
- What is my exact diagnosis — the type, subtype, stage, and grade?
- Has my tumor had molecular or genomic testing (e.g. next-generation sequencing), and what did it find?
- Should I have inherited (germline) genetic testing, and could it affect my treatment or my family?
- What is the goal of treatment for me — cure, long-term control, or comfort?
- What are all of my standard treatment options, and what does each one involve?
- What is the realistic benefit of each option, in actual numbers?
- What are the most common and the most serious side effects, and how are they managed?
- How will we know if treatment is working, and how often will I be scanned or tested?
- If the first treatment doesn't work, what are the next options?
- Are there gentler options if I want to prioritize quality of life?
- Am I eligible for any clinical trials — here or at a larger/academic cancer center?
- Is my case reviewed by a multidisciplinary tumor board?
- Would a second opinion at a center that treats my cancer often be worthwhile?
- Could any of my prescriptions, over-the-counter drugs, or supplements interfere with treatment?
- Which symptoms are emergencies, and who do I call after hours?
- Should I see palliative or supportive care alongside my treatment?
- How will treatment affect my daily life, work, and (if it matters to me) fertility?
- What can I safely do myself — diet and activity — and is anything I'm taking risky?
- What will treatment cost, and is financial assistance available?
- Should my tumor tissue be stored (biobanked) for future testing or trials?